Thomas Story & Son LLC Merck & Co., Inc. Transaction History
Thomas Story & Son LLC
- $270 Million
- Q3 2025
A detailed history of Thomas Story & Son LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Thomas Story & Son LLC holds 76,733 shares of MRK stock, worth $6.44 Million. This represents 2.38% of its overall portfolio holdings.
Number of Shares
76,733
Previous 54,560
40.64%
Holding current value
$6.44 Million
Previous $4.32 Million
49.14%
% of portfolio
2.38%
Previous 1.68%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,853Shares Held
1.96BCall Options Held
29.2MPut Options Held
30M-
Vanguard Group Inc Valley Forge, PA253MShares$21.2 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA118MShares$9.94 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA76.9MShares$6.45 Billion1.15% of portfolio
-
Geode Capital Management, LLC Boston, MA59MShares$4.95 Billion0.34% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $213B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...